-
-
-
-
-
-
-
Provention Bio Inc. (PRVB) PT Lowered to $22.50 at Chardan Capital Markets Following FDA AdComm Vote
-
-
-
-
-
-
-
Chardan Expands Research Team, Welcomes Managing Director and Director of Research
-
-
-
-
-
-
-
Buy Solid Biosciences (SLDB) on Weakness - Chardan Capital
-
-
-
-
-
-
-
uniQure to Participate in Multiple Upcoming Industry Conferences in October
-
-
-
-
-
-
-
UPDATE: Chardan Capital Markets Upgrades Adverum Biotechnologies (ADVM) to Buy
-
-
-
-
-
-
-
Chardan Capital Markets Downgrades The Medicines Company (MDCO) to Neutral on Valuation, Removes as Top Pick
-
-
-
-
-
-
-
Audentes Therapeutics (BOLD) PT Raised to $50 at Chardan Capital Markets
-
151 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

